News

FDA announced it has awarded 510(k) clearance for expanded indications of the Masimo O3 Regional Oximetry System to include various delta hemoglobin parameters (ΔcHb, ΔHHb and ΔO 2 Hb) to display ...
The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...
Dr. Whitten is the author of “Anyone Can Intubate: A Step–by–Step Guide to Intubation and Airway Management” and “Pediatric Airway ...
There remains a need for organizations and stakeholders to develop guidance for prescribing ketamine as a pain treatment.
Despite its analgesic, anti-inflammatory and bio-stimulating effects, laser therapy is currently underutilized by the medical community due to a lack of knowledge ...
Sugammadex is widely used for reversal of muscle relaxation with steroidal neuromuscular blocking agents including rocuronium ...
Originally published by our sister publication Pain Medicine News The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair ...
Practicing U.S. based physicians that are registered with the American Medical Association (AMA) or American Osteopathic Association (AOA) as an anesthesiologist may qualify to receive print edition ...
The APSF has issued four recommendations for patient monitoring during anesthesia that further bolster patient safety and help prevent postoperative complications.
Tracheal intubation of patients with a physiologically difficult airway continues to be associated with a high incidence of complications, including ...